Page-4 of Clinical medicine Current Affairs, GK & News
In March, 2018, the Union Health Ministry has released the National Anti-TB Drug Resistance Survey report. The findings of the report include: India which is home to 2.8 million TB patients, the largest in the world of which over a quarter of patients in India could be resistant to one or more drugs that can ..
Topics: Antibiotic-resistant bacteria • Clinical medicine • Extensively drug-resistant tuberculosis • Health • Medicine • Multi-drug-resistant tuberculosis • Multiple drug resistance • Totally drug-resistant tuberculosis • Tuberculosis • Tuberculosis in India • XDR
Tuberculosis is caused by various strains of mycobacterium, usually Mycobacterium tuberculosis. It usually attacks the lungs but can also affect other parts of the body. National Tuberculosis Control Programme was started in 1962 on a 50:50 sharing basis between Centre and State. The objectives of the Programme were to reduce the morbidity and mortality; to ..
Topics: Clinical medicine • Directly observed treatment, short-course • Infectious diseases • Medicine • Mycobacterium • Revised National Tuberculosis Control Program • Tuberculosis • Tuberculosis in India • Tuberculosis management • World Tuberculosis Day
The Union Ministry of Science and Technology has launched SOHUM, an indigenously developed low-cost hearing screening device for newborns. The innovative medical device has been developed by the School of International Biodesign (SIB) startup Sohum Innovation Labs India Pvt Ltd under Department of Biotechnology (DBT) supported (SIB) The Sohum aims to make this battery-operated non-invasive screening device available ..
Recently, the scientists have developed a new cancer drug that kills aggressive and deadly tumours by altering the structure of the cancer growth protein. The scientists, led by David A. Cheresh, PhD, professor of pathology and associate director for translational research at the Moores Cancer Center, used an innovative chemical and biological approach to design ..
Lynch Syndrome is a genetic anomaly that predisposes a person to developing colorectal cancer and a range of other solid organ cancers. Recently it has been found that Aspirin, the drug used by millions of people to protect their heart, has been found to drastically reduce colorectal cancer rates among those who have an increased ..
Topics: Antipyretic • Aspirin • Cancer • Clinical medicine • Colorectal cancer • Commercialization of traditional medicines • Drugs • Hepatotoxins • Hereditary nonpolyposis colorectal cancer • Medicine • Nonsteroidal anti-inflammatory drugs • RTT